EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity

Shuyu Xu, Yang Song, Tianjiao Zhang, Yan Wang, Mengxin Wang, Xinxin Xie, Qingfeng Chen, Xiaolong Liang

Exploration · 2026-10 · 6 (5)

DOI: 10.1002/exp2.70238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration, online erschienen am 11.10.2026. Verfasst von Shuyu Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, Department of Ultrasound Peking University Third Hospita…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant advances in nanovaccine development, their efficacy remains hindered by poor antigen presentation, limited antigen repertoire, and suboptimal T cell priming. Immune adjuvants such as polyinosinic‐polycytidylic acid (POLY(I:C)) exert antitumor effects by promoting dendritic cell (DC) maturation and stimulating innate immunity, but their efficacy is limited by poor antigen presenting cell (APC) uptake and weak CD8 + T cell responses. Here, we propose a novel adjuvant strategy using nitric oxide (NO), a bioactive gaseous molecule, to upregulate MHC‐I and enhance DC cross‐presentation, thereby synergistically improving the adjuvant efficacy of POLY(I:C). We developed a nanovaccine, Im@NOnanoPL, by co‐encapsulating a preassembled complex of DOTAP, NOC‐18, and POLY(I:C) into a PLGA shell, which was further modified with DSPE‐PEG 2000 and camouflaged with immunogenic cell death (ICD)–derived tumor membranes for broad‐spectrum tumor antigen coverage. Im@NOnanoPL elicited robust and durable CD8 + T cell responses, conferring near‐complete prophylactic protection and, in combination with αPD‐1 therapy, eradicating established tumors while inducing long‐term immune memory. Im@NOnanoPL constitutes a novel vaccine platform that integrates a gas‐based adjuvant with broad‐spectrum antigens, exhibiting strong translational potential.

Schlagwörter

Stichwörter der Autor:innen

gas vaccine adjuvantnanovaccinenitric oxidetumor vaccine

Autor:innen und Institutionen

  • Beijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, Department of Ultrasound Peking University Third Hospital Beijing P. R. China.
  • Department of Ultrasound Medicine, Beijing Chaoyang Hospital Capital Medical University Chaoyang Beijing China.
  • Department of Ultrasound The First Affiliated Hospital of China Medical University Shenyang China.
  • Institute of Molecular and Cell Biology Agency For Science, Technology and Research Singapore Singapore.
  • State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Key Laboratory of Interdisciplinary Research in Gastrointestinal Oncology (BLGO) Peking University Third Hospital Beijing P. R. China.

Förderung

  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Xu, S., Song, Y., Zhang, T., Wang, Y., Wang, M., Xie, X., Chen, Q., & Liang, X. (2026). A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity. Exploration, 6(5). https://doi.org/10.1002/exp2.70238

Vancouver

Xu S, Song Y, Zhang T, Wang Y, Wang M, Xie X, et al. A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity. Exploration. 2026;6(5). doi:10.1002/exp2.70238

BibTeX
@article{Xu2026,
  author = {Xu, Shuyu and Song, Yang and Zhang, Tianjiao and Wang, Yan and Wang, Mengxin and Xie, Xinxin and Chen, Qingfeng and Liang, Xiaolong},
  title = {A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity},
  journal = {Exploration},
  year = {2026},
  volume = {6},
  number = {5},
  doi = {10.1002/exp2.70238}
}
Kostenlos starten →